Decision Support Tool for Newly Diagnosed Localised Prostate Cancer
Part of Cancer clinical trials.
This trial is testing a new decision support tool (BeSpoke) to help men with newly diagnosed localised prostate cancer make informed choices about their treatment. If you are deciding between two or more standard treatments, this tool may help you and your doctor pick the best one for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have just been diagnosed with prostate cancer that is still only in the prostate (localised).
- Your doctor has said you are suitable for at least two of these treatments: active surveillance, focal therapy, surgery to remove the prostate, or external beam radiation.
- You are willing and able to sign a consent form to join the study.
- You can understand English well enough to use the decision support tool, or you have a family member or friend who can help you with it.
- You do not have signs that the cancer has spread (like a PSA of 50 or higher, or suspicious spots on scans).
- You are not already in another prostate cancer study where your treatment is assigned by the study (rather than you choosing).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well new computer methods (called algorithms and machine learning) can support radiation therapy decisions. You might benefit by helping improve how radiation is planned and checked, especially for cancers treated with curative-intent therapy.
This trial tests an English computer tool that gives feedback during prostate cancer treatment visits. It aims to help you and your clinician make more informed, shared decisions about next treatment steps.
This trial tests an English decision aid (a patient guide) to help older men understand and feel comfortable with “active surveillance” for localized prostate cancer. It also checks how easy to use it is for patients, caregivers, and prostate cancer clinicians.
This trial tests a computer tool that analyzes your conversations with doctors. It aims to help you make a more informed choice about prostate cancer treatment.
This study tests a decision aid to help men aged 65 and older with early-stage prostate cancer decide whether to choose active surveillance (monitoring the cancer instead of immediate treatment). The goal is to see if the tool helps men and their care partners make a more informed choice.
This trial tests a digital program to help men with early-stage prostate cancer manage their care. It uses a patient portal to provide support and information alongside your usual treatment.
Hear when a new Localised Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.